Clinical trial Recruiting at 1 site Interventional Ages 40 to 75

Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis

Official title: Changes in Serum IGF-1 Levels With Resistance Exercises in Patients With Knee Osteoarthritis and Their Association With Clinical and Radiological Parameters

Run by Sisli Hamidiye Etfal Training and Research Hospital · NCT07890155 · Data updated 2026-11-12

A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.

Quick facts

Study typeInterventional
Ages40 Years to 75 Years
SexAll
Enrollment86 (estimated)
SponsorSisli Hamidiye Etfal Training and Research Hospital
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedJune 1, 2026
Main results expectedDecember 1, 2026
Study endsJanuary 2027
Registry record updatedOctober 22, 2026
Trial IDNCT07890155 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–75 with knee OA (KL grade 2–3) who have recent knee MRI and consent to an 8-week resistance program.

Probably not a fit

Individuals with severe comorbidities or contraindications to resistance exercise may not experience benefit or may be excluded from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, single-center study examines whether eight weeks of resistance training alter serum IGF-1 and whether those changes relate to improvements in pain and function, as well as radiographic features. Participants include adults aged 40–75 with Kellgren-Lawrence grade 2–3 knee OA, some with metabolic syndrome characteristics. Researchers will compare pre- and post-intervention IGF-1, clinical scores (WOMAC, VAS), and MOAKS osteophyte scores to explore potential associations and the modifying effect of the metabolic phenotype. The trial is non-randomized and non-blinded, with participants allocated into two predefined groups based on phenotype. The lead site is in Istanbul, Turkey, at Sisli Hamidiye Etfal Training and Research Hospital.

Why it matters

Potential benefit: If successful, the study could clarify a biochemical link between resistance exercise and OA symptom relief mediated by IGF-1, informing tailored rehabilitation strategies.

How similar studies have gone: Previous work suggests resistance exercise can influence biomarkers and symptoms in knee OA, but this specific IGF-1–metabolic phenotype interaction is an area of ongoing investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of knee osteoarthritis according to the American College of Rheumatology (ACR) clinical and radiographic criteria.
* Radiological severity of Kellgren-Lawrence (KL) grade 2 or 3 on standing anteroposterior knee radiographs
* Having a knee magnetic resonance imaging (MRI) scan obtained within the past 1 year
* Age between 40 and 75 years
* Volunteering to participate in the study and signing the informed consent form

Exclusion Criteria:

* Receiving intra-articular injections (e.g., corticosteroids, hyaluronic acid, PRP) in the affected knee within the last 6 months
* History of previous major knee surgery, knee arthroplasty, or lower extremity trauma affecting biomechanics
* Diagnosis of rheumatoid arthritis, or other inflammatory joint diseases
* Presence of severe cardiovascular, neurological, or musculoskeletal disorders that would contraindicate or prevent participation in a structured resistance exercise program
* History of malignancy or presence of active malignancy
* Presence of active infection
* Cognitive impairment or inability to understand and follow the exercise instructions and questionnaires

Where it's running

  • Sisli Hamidiye Etfal Training and Research Hospital
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Kadriye Banu Kuran, MD, Prof. — Sisli Hamidiye Etfal Training and Research Hospital
  • Study coordinator: Bora Şahin, MD, PMR resident physician
  • Email: borashn55@gmail.com
  • Phone: +905386673139

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.